Cardiovascular effects of centrally applied endothelin-11-31 and its relationship to endothelin-11-21 in rats

Autonomic Neuroscience: Basic and Clinical

Volumn 133, Issue 2, 2007, Pages 146-152

  Lu, Yan ^a,b   Wang, Li Gang ^a   Liao, Zhuan ^c   Tang, Chao Shu ^d   Wang, Wei Zhong ^a   Yuan, Wen Jun ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b San Aitang Hospital   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

^d PEKING UNIVERSITY   (China)

Author keywords

Blood pressure; Endothelin 1; ET converting enzyme; ET receptors; Lateral cerebral ventricle; Rat

Indexed keywords

AMINO ACID; CHYMASE; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1 [1-21]; ENDOTHELIN 1 [1-31]; ENDOTHELIN 1 DERIVATIVE; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; PHOSPHORAMIDON; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; HEART RATE; HYDROLYSIS; LATERAL BRAIN VENTRICLE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ASPARTIC ENDOPEPTIDASES; BLOOD PRESSURE; CARDIOVASCULAR PHYSIOLOGY; CARDIOVASCULAR SYSTEM; ENDOTHELIN-1; ENZYME INHIBITORS; INJECTIONS, INTRAVENTRICULAR; MALE; METALLOENDOPEPTIDASES; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN A;

EID: 34247209594     PISSN: 15660702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autneu.2006.11.004     Document Type: Article

References (40)

1. Ahn K., Herman S.B., and Fahnoe D.C. Soluble human endothelin-converting enzyme-1: expression, purification, and demonstration of pronounced pH sensitivity. Arch. Biochem. Biophys. 359 2 (1998) 258-268
2. Baltatu O., Nishimura H., Hoffmann S., et al. High levels of human chymase expression in the pineal and pituitary glands. Brain Res. 752 1-2 (1997) 269-278
3. Cao W.H., Kuwaki T., Unekawa M., et al. Action of endothelin-1 on vasomotor neurons in rat rostral ventrolateral medulla. J. Cardiovasc. Pharmacol. 22 Suppl 8 (1993) S196-S198
4. Dai S.M., Shan Z.Z., Miao C.Y., et al. Hemodynamic responses to endothelin-1 and endothelin antagonists microinjected into the nucleus tractus solitarius in rats. J. Cardiovasc. Pharmacol. 30 4 (1997) 475-480
5. Fecteau M.H., Honore J.C., Plante M., et al. Endothelin-1 (1-31) is an intermediate in the production of endothelin-1 after big endothelin-1 administration in vivo. Hypertension 46 1 (2005) 87-92
6. Ferguson A.V., and Smith P. Cardiovascular responses induced by endothelin microinjection into area postrema. Regul. Pept. 27 1 (1990) 75-85
7. Giaid A., Gibson S.J., Ibrahim B.N., et al. Endothelin 1, an endothelium-derived peptide, is expressed in neurons of the human spinal cord and dorsal root ganglia. Proc. Natl. Acad. Sci. U. S. A. 86 19 (1989) 7634-7638
8. Gulati A., and Rebello S. Characteristics of endothelin receptors in the central nervous system of spontaneously hypertensive rats. Neuropharmacology 31 3 (1992) 243-250
9. Gulati A., Rebello S., Roy S., et al. Cardiovascular effects of centrally administered endothelin-1 in rats. J. Cardiovasc. Pharmacol. 26 Suppl 3 (1995) S244-S246
10. Gulati A., Kumar A., and Shahani B.T. Cardiovascular effects of centrally administered endothelin-1 and its relationship to changes in cerebral blood flow. Life Sci. 58 5 (1996) 437-445
11. Gulati A., Kumar A., Morrison S., et al. Effect of centrally administered endothelin agonists on systemic and regional blood circulation in the rat: role of sympathetic nervous system. Neuropeptides 31 4 (1997) 301-309
12. Gulati A., Rebello S., and Kumar A. Role of sympathetic nervous system in cardiovascular effects of centrally administered endothelin-1 in rats. Am. J. Physiol. 273 3 Pt 2 (1997) H1177-H1186
13. Hanson G.C., Andersson K.E., Gyllstedt E., et al. Hydrolysis of big endothelin-1 by a serine protease in the membrane fraction of human lung. Regul. Pept. 68 1 (1997) 63-69
14. Hashim M.A., and Tadepalli A.S. Functional evidence for the presence of a phosphoramidon-sensitive enzyme in rat brain that converts big endothelin-1 to endothelin-1. Life Sci. 49 24 (1991) PL207-PL211
15. Hayasaki-Kajiwara Y., Naya N., Shimamura T., et al. Endothelin generating pathway through endothelin1-31 in human cultured bronchial smooth muscle cells. Br. J. Pharmacol. 127 6 (1999) 1415-1421
16. Hoyer D., Waeber C., and Palacios J.M. [125I]endothelin-1 binding sites: autoradiographic studies in the brain and periphery of various species including humans. J. Cardiovasc. Pharmacol. 13 Suppl 5 (1989) S162-S165
17. Inui D., Yoshizumi M., Suzaki Y., et al. Effect of endothelin-1(1-31) on p38 mitogen-activated protein kinase in cultured human mesangial cells. Life Sci. 68 6 (2000) 635-645
18. Jones C.R., Hiley C.R., Pelton J.T., et al. Autoradiographic visualization of the binding sites for [125I]endothelin in rat and human brain. Neurosci. Lett. 97 3 (1989) 276-279
19. Kumada M., Cao W., and Kuwaki T. Effect of endothelin on vasomotor and respiratory neurons in the rostral ventrolateral medulla in rats. Cell. Mol. Neurobiol. 23 4-5 (2003) 691-707
20. Kumar A., Shahani B.T., and Gulati A. Modification of systemic and regional circulatory effects of intracerebroventricular administration of endothelin-1 by propranolol in anesthetized rats. Gen. Pharmacol. 27 6 (1996) 1025-1033
21. Kuwaki T., Cao W.H., and Kumada M. Endothelin in the brain and its effect on central control of the circulation and other functions. Jpn. J. Physiol. 44 1 (1994) 1-18
22. Kuwaki T., Kurihara H., Cao W.H., et al. Physiological role of brain endothelin in the central autonomic control: from neuron to knockout mouse. Prog. Neurobiol. 51 5 (1997) 545-579
23. Lu Y., Lin L., and Yuan W.J. A novel member of endothelin family-endothelins1-31. Sheng Li Ke Xue Jin Zhan 36 1 (2005) 41-44
24. 1-21. J. Cardiovasc. Pharmacol. 46 6 (2005) 823-829
25. MacCumber M.W., Ross C.A., and Snyder S.H. Endothelin in brain: receptors, mitogenesis, and biosynthesis in glial cells. Proc. Natl. Acad. Sci. U. S. A. 87 6 (1990) 2359-2363
26. Masliniska D., Dambska M., Kaliszek A., et al. Accumulation, distribution and phenotype heterogeneity of mast cells (MC) in human brains with neurocysticercosis. Folia Neuropathol 39 1 (2001) 7-13
27. Matsumura K., Abe I., Tsuchihashi T., et al. Central effect of endothelin on neurohormonal responses in conscious rabbits. Hypertension 17 6Pt 2 (1991) 1192-1196
28. Mortensen L.H. Endothelin and the central and peripheral nervous systems: a decade of endothelin research. Clin. Exp. Pharmacol. Physiol. 26 12 (1999) 980-984
29. Mosqueda-Garcia R., Yates K., O'Leary J.I., et al. Cardiovascular and respiratory effects of endothelin in the ventrolateral medulla of the normotensive rat. Hypertension 26 2 (1995) 263-271
30. Nakamura K., Sasaki S., Moriguchi J., et al. Central effects of endothelin and its antagonists on sympathetic and cardiovascular regulation in SHR-SP. J. Cardiovasc. Pharmacol. 33 6 (1999) 876-882
31. Nakano A., Kishi F., Minami K., et al. Selective conversion of big endothelins to tracheal smooth muscle-constricting 31-amino acid-length endothelins by chymase from human mast cells. J. Immunol. 159 4 (1997) 1987-1992
32. Nambi P., Pullen M., and Feuerstein G. Identification of endothelin receptors in various regions of rat brain. Neuropeptides 16 4 (1990) 195-199
33. Nunez D.J., Brown M.J., Davenport A.P., et al. Endothelin-1 mRNA is widely expressed in porcine and human tissues. J. Clin. Invest. 85 5 (1990) 1537-1541
34. Ono N., and Kaneko M. Influences of beta-blocking agents on cardiovascular actions induced by endothelin-3 administered intracerebroventricularly in anesthetized rats. Life Sci. 57 4 (1995) 345-353
35. Ozawa Y., Hasegawa T., Tsuchiya K., et al. Effect of endothelin-1 (1-31) on the renal resistance vessels. J. Med. Investig. 50 1-2 (2003) 87-94
36. Shinyama H., Uchida T., Kido H., et al. Phosphoramidon inhibits the conversion of intracisternally administered big endothelin-1 to endothelin-1. Biochem. Biophys. Res. Commun. 178 1 (1991) 24-30
37. Warner T.D., Budzik G.P., Matsumoto T., et al. Regional differences in endothelin converting enzyme activity in rat brain: inhibition by phosphoramidon and EDTA. Br. J. Pharmacol. 106 4 (1992) 948-952
38. Yanagisawa M., Kurihara H., Kimura S., et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332 6163 (1988) 411-415
39. Yasuoka H., Yoshizumi M., Inui D., et al. Effect of endothelin-1(1-31) on intracellular free calcium in cultured human mesangial cells. Life Sci. 65 22 (1999) PL267-PL1272
40. Yoshizumi M., Inui D., Kirima K., et al. Comparison of the effects of endothelin-1, -2 and -3 (1-31) on changes in [Ca2+]i in human coronary artery smooth muscle cells. Jpn. J. Pharmacol. 81 3 (1999) 298-304